CD4 and Parkinson disease: In a PD mouse model, abnormalities in the DRD3 protein expressed on CD4+ T cells were seen to reduce neuroinflammation and neurodegeneration, suggesting that the DRD3 expressed on CD4+ T cells facilitates disease progression (González et al., 2013).